118 related articles for article (PubMed ID: 16010685)
1. Rapid recognition of aberrant dHPLC elution profiles using the Transgenomic Navigator software.
Colley J; Jones S; Dallosso AR; Maynard JH; Humphreys V; Dolwani S; Sampson JR; Cheadle JP
Hum Mutat; 2005 Aug; 26(2):165. PubMed ID: 16010685
[TBL] [Abstract][Full Text] [Related]
2. NF1 gene analysis based on DHPLC.
De Luca A; Buccino A; Gianni D; Mangino M; Giustini S; Richetta A; Divona L; Calvieri S; Mingarelli R; Dallapiccola B
Hum Mutat; 2003 Feb; 21(2):171-2. PubMed ID: 12552569
[TBL] [Abstract][Full Text] [Related]
3. DHPLC screening of cystic fibrosis gene mutations.
Ravnik-Glavac M; Atkinson A; Glavac D; Dean M
Hum Mutat; 2002 Apr; 19(4):374-83. PubMed ID: 11933191
[TBL] [Abstract][Full Text] [Related]
4. Random mutagenesis-PCR to introduce alterations into defined DNA sequences for validation of SNP and mutation detection methods.
Nickerson ML; Warren MB; Zbar B; Schmidt LS
Hum Mutat; 2001 Mar; 17(3):210-9. PubMed ID: 11241843
[TBL] [Abstract][Full Text] [Related]
5. The use of denaturing high performance liquid chromatography (DHPLC) for mutation scanning of hereditary cancer genes.
Marsh DJ; Howell VM
Methods Mol Biol; 2010; 653():133-45. PubMed ID: 20721741
[TBL] [Abstract][Full Text] [Related]
6. Development of a denaturing high-performance liquid chromatography screening method for SMAD4 in juvenile polyposis syndrome.
Hatch SL; Trewick AL; Payne SJ
Ann Clin Biochem; 2007 Mar; 44(Pt 2):159-63. PubMed ID: 17362581
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of denaturing high performance liquid chromatography for the mutational analysis of the MEN1 gene.
Crépin M; Pigny P; Escande F; Bauters CC; Calender A; Lefevre S; Buisine MP; Porchet N; Odou MF
J Mol Endocrinol; 2006 Apr; 36(2):369-76. PubMed ID: 16595707
[TBL] [Abstract][Full Text] [Related]
8. Identification of specific BRCA1 and BRCA2 variants by DHPLC.
Gross E; Arnold N; Pfeifer K; Bandick K; Kiechle M
Hum Mutat; 2000 Oct; 16(4):345-53. PubMed ID: 11013445
[TBL] [Abstract][Full Text] [Related]
9. Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection.
O'Donovan MC; Oefner PJ; Roberts SC; Austin J; Hoogendoorn B; Guy C; Speight G; Upadhyaya M; Sommer SS; McGuffin P
Genomics; 1998 Aug; 52(1):44-9. PubMed ID: 9740670
[TBL] [Abstract][Full Text] [Related]
10. Denaturing HPLC-based approach for detection of COL7A1 gene mutations causing dystrophic epidermolysis bullosa.
Posteraro P; Pascucci M; Colombi M; Barlati S; Giannetti A; Paradisi M; Mustonen A; Zambruno G; Castiglia D
Biochem Biophys Res Commun; 2005 Dec; 338(3):1391-401. PubMed ID: 16271705
[TBL] [Abstract][Full Text] [Related]
11. Denaturing temperature selection may underestimate keratin mutation detection by DHPLC.
Strnad P; Lienau TC; Tao GZ; Ku NO; Magin TM; Omary MB
Hum Mutat; 2006 May; 27(5):444-52. PubMed ID: 16575832
[TBL] [Abstract][Full Text] [Related]
12. Rapid and accurate detection of atypical and Kalow variants in the butyrylcholinesterase gene using denaturing high performance liquid chromatography.
Levano S; Keller D; Schobinger E; Urwyler A; Girard T
Anesth Analg; 2008 Jan; 106(1):147-51, table of contents. PubMed ID: 18165570
[TBL] [Abstract][Full Text] [Related]
13. Denaturing high-performance liquid chromatography for mutation detection and genotyping.
Fackenthal DL; Chen PX; Das S
Methods Mol Biol; 2005; 311():73-96. PubMed ID: 16100401
[TBL] [Abstract][Full Text] [Related]
14. Denaturing HPLC for mutation screening.
Mitchell M; Cutler J
Methods Mol Biol; 2011; 688():17-33. PubMed ID: 20938830
[TBL] [Abstract][Full Text] [Related]
15. Denaturing high-performance liquid chromatography for mutation detection and genotyping.
Fackenthal DL; Chen PX; Howe T; Das S
Methods Mol Biol; 2013; 1015():25-54. PubMed ID: 23824847
[TBL] [Abstract][Full Text] [Related]
16. Rapid screening of the entire mitochondrial DNA for low-level heteroplasmic mutations.
Meierhofer D; Mayr JA; Ebner S; Sperl W; Kofler B
Mitochondrion; 2005 Aug; 5(4):282-96. PubMed ID: 16050991
[TBL] [Abstract][Full Text] [Related]
17. Clinical applications of denaturing high-performance liquid chromatography-based genotyping.
Danielson PB; Shelton RJ; LaBerge GS
Croat Med J; 2003 Aug; 44(4):447-54. PubMed ID: 12950149
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of denaturing high-performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall-cell lung cancer.
Cohen V; Agulnik JS; Jarry J; Batist G; Small D; Kreisman H; Tejada NA; Miller WH; Chong G
Cancer; 2006 Dec; 107(12):2858-65. PubMed ID: 17096434
[TBL] [Abstract][Full Text] [Related]
19. Mutation analysis of the hamartin gene using denaturing high performance liquid chromatography.
Bénit P; Kara-Mostefa A; Berthelon M; Sengmany K; Munnich A; Bonnefont JP
Hum Mutat; 2000 Nov; 16(5):417-21. PubMed ID: 11058899
[TBL] [Abstract][Full Text] [Related]
20. [Influence of DNA polymerases on mutation screening of denaturing high-performance liquid chromatography].
Liu MR; Pan KF; Wang Y; Lu YY
Ai Zheng; 2002 Oct; 21(10):1160-3. PubMed ID: 12508666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
